Evidence map›Paper›PMID 41663729›Full record

ArticleScientific reports2026

γ-Fe

Sara Sobhani, Hamideh Kargar Bidokhti, Alireza Farrokhi, José Miguel Sansano

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sara SobhaniDepartment of Chemistry, College of Science, Shiraz University, Shiraz, Iran. sarasobhani@saadi.shirazu.ac.ir.
Hamideh Kargar BidokhtiDepartment of Chemistry, College of Sciences, University of Birjand, Birjand, Iran.
Alireza FarrokhiDepartment of Chemistry, College of Sciences, University of Birjand, Birjand, Iran.
José Miguel SansanoDepartamento de Química Orgánica, Centro de Innovación en Química Avanzada (ORFEO- CINQA), Instituto de Síntesis Orgánica, Universidad de Alicante, Apdo. 99, Alicante, 03080, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, γ-Fe2O3/MIL101(Fe)-NH2/COF-MT, a hybrid material, capable of absorbing visible light, was designed and synthesized easily through growth of COF-MT by imine bond formation using amine groups of supported melamine on γ-Fe2O3/MIL101(Fe)-NH2. The structure, morphology and optical properties of γ-Fe2O3/MIL101(Fe)-NH2/COF-MT were investigated using various techniques, including FT-IR, UV-vis DRS, PXRD, TGA, XPS, FESEM, EDS mapping, TEM, VSM, BET, BJH, PL, ICP, EIS and Mott-Schottky plots. This hybrid material was effectively utilized as a ternary heterostructure photocatalyst to achieve efficient and selective oxidation of alcohols into aldehydes under sunlight irradiation and air bubbling in ethanol. The remarkably improved photocatalytic performance is attributed to enhanced charge separation, increased visible light absorption, and the strengthened redox capabilities of photogenerated electrons and holes through a dual S-scheme charge transfer mechanism. Based on our knowledge, this is the first report on the photo-oxidation of alcohols catalyzed by γ-Fe2O3/MOF/COF as a hybrid material. This work highlights the potential of γ-Fe2O3/MIL101(Fe)-NH2/COF-MT as a sustainable catalyst for the synthesis of aldehydes as fine chemicals due to the improved light absorption and charge separation, energy-saving (sunlight irradiation), mild reaction conditions (room temperature and ambient pressure), using a small amount of the catalyst, air as a safe and plentiful oxidant (generating water as the only by-product), ethanol as a green solvent, and the ease of catalyst isolation and reuse by an external magnet without a remarkable change in the catalyst structure and activity.

Indexed as

AlcoholsCOFDual s-schemeHybridMOFPhoto-oxidation

Identifiers

PMID41663729
PMCPMC12960850

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.